Metallo-β-lactamase (MBL) producing bacteria constitute nowadays a serious global concern worldwide. The purpose of our present study was to characterize molecular features of MBL producing bacteria and to identify the existing clones in our area. Thirteen MBL-producing-Klebsiella pneumoniae were detected in clinical samples from patients hospitalized in the Military hospital of Tunisia during 2017. The molecular research by polymerase chain reaction and sequencing of gene encoding MBL enzymes showed that only two types were identified in our study: blaNDM-1 and blaVIM-1 genes detected, respectively, in eight and six isolates. An association between these two MBL genes (blaNDM-1+blaVIM-1) has been observed in one of our isolates. Other β-lactamase types (CTXM-15/4 isolates; SHV/2 isolates; OXA-48/3 isolates) were detected in association with New Delhi metallo-beta-lactamase (NDM) and/or Verona Integron-Mediated Metallo-β-lactamase (VIM) enzymes. Furthermore, these isolates were resistant to other antimicrobial agents, including gentamicin [aac(3)-II/11 isolates], tetracycline (tetB or tetA/2 isolates), chloramphenicol (cmlA and/or floR/3 isolates), streptomycin (aadA/5 isolates), and sulfonamides (sul1 or sul2 or sul3/4isolates). The Multilocus Sequence Typing revealed 10 different Sequence types (ST) of which 7 novel ST: ST147 (3 isolates), ST101 (1 isolate), ST630 (1 isolate), ST3485 (1 isolate), ST3486 (1 isolate), ST3487 (1 isolate), ST3488 (1 isolate), ST3489 (1 isolate), ST3490 (1 isolate), ST3491 (2 isolates). Our study provides new data about MBL producing K. pneumoniae in Tunisia. Thus, we report for the first time the coexpression of blaNDM-1 and blaVIM-1 in our country and also we describe seven novel ST of MBL producing K. pneumoniae in the world.
Get full access to this article
View all access options for this article.
References
1.
PalzkillT.2013. Metallo-β-lactamase structure and function. Ann. N. Y. Acad. Sci. 1277:91–104.
2.
MojicaM.F., BonomoR.A, and FastW.2016. B1-metallo-beta-lactamases: where do we stand? Curr. Drug Targets, 17:1029–1050.
3.
SomboroA.M., SekyereJ.O, AmoakoD.G, EssackS.Y, and BesterL.A.2018. Diversity and proliferation of metallo-β-lactamases: a clarion call for clinically effective metallo-β-lactamase inhibitors. Appl. Environ. Microbiol. 84:pii: e00698–18.
4.
KangC.I., KimS.H, ParkW.B, LeeK.D, KimH.B, KimE.C, OhM., and ChoeK.W.2015. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob. Agents Chemother. 49:760–766.
5.
WalshT.2005. The emergence and implications of metallo-β-lactamases in Gram-negative bacteria. Clin. Microbiol. Infect. 11:2–9.
6.
WalshT.2010. Emerging carbapenemases: a global perspective. Int. J. Antimicrob. Agents, 36:S8–S14.
7.
BonomoR.A., BurdE.M, ConlyJ., LimbagoB.M, PoirelL., SegreJ.A, and WestbladeL.F.2018. Carbapenemase-producing organisms: a global scourge. Clin. Infect. Dis. 66:1290–1297.
8.
KtariS., ArletG., MnifB., GautierV., MahjoubiF., Ben JmeaaM., BouazizM., and HammamiA.2006. Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-β-lactamase, CTX-M-15 extended-spectrum β-lactamase, and CMY-4 AmpC β-lactamase in a Tunisian University Hospital. Antimicrob. Agents Chemother., 50:4198–4201.
9.
Ben NasrA., DecréD., CompainF., GenelN., BarguellilF., and ArletG.2013. Emergence of NDM-1 in association with OXA-48 in Klebsiella pneumoniae from Tunisia. Antimicrob. Agents Chemother. 57:4089–4090.
10.
ChouchaniC., MarrakchiR., FerchichiL., El SalabiA., and WalshT.2011. VIM and IMP metallo-β-lactamases and other extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae from environmental samples in a Tunisian hospital. APMIS. 119:725–732.
11.
MessaoudiA., HaenniM., MansourW., SarasE., Bel Haj KhalifaA., ChaouchC., NaijaW., BoujâafarN., BouallègueO., and MadecJ.2017. ST147 NDM-1-producing Klebsiella pneumoniae spread in two Tunisian hospitals. J. Antimicrob. Chemother. 72:315–316.
12.
DziriO., AlonsoC.A, DziriR., GhrasaH., MaraoubA., TorresC., and ChouchaniC.2018. Metallo-β-lactamases and class D carbapenemases in south-east Tunisia: implication of mobile genetic elements in their dissemination. Int. J. Antimicrob. Agents, 52:871–877.
13.
HamzaouiZ., Ocampo-SosaA., MaamarE., Fernandez MartinezM., FerjaniS., HammamiS., HarbaouiS., GenelN., AlertG., SaidaniM., SlimA., Boutiba-Ben BoubakerI., and Martinez-MartinezL.2018. An outbreak of NDM-1-producing Klebsiella pneumoniae associated with OmpK35 and OmpK36 porin loss in Tunisia. Microb. Drug Resist. 24:1137–1147.
14.
MoussoundaM., DieneS.M, Dos SantosS., GoudeauA., FrançoisP., and Van der Mee-MarquetN.2017. Emergence of blaNDM-7 producing Enterobacteriaceae in Gabon, 2016. Emerg. Infect. Dis. 23:356–358.
15.
Ben HelalR., DziriR., ChedlyM., KlibiN., BarguellilF., El AsliM.S, and Ben MoussaM.2018. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae in a Tunisian hospital. Microb. Drug Resist. 24:1361–1367.
16.
WangY., TongM.K, ChowK.H, ChengV.C.C, TseC.W.S, WuA.K.L, LaiR.W.M, LukW.K, TsangD.N.C, and HoP.L. 2018. Occurrence of highly conjugative IncX3 epidemic plasmid carrying blaNDM in Enterobacteriaceae isolates in geographically widespread areas. Front. Microbiol., 9:2272.
17.
FrankJ.A., ReichC.I, SharmaS., WeisbaumJ.S, WilsonB.A, and OlsenG.J.2008. Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes. Appl. Environ. Microbiol. 74:2461–2470.
18.
EllingtonM.J., KistlerJ., LivermoreD.M, and WoodfordN.2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases. J. Antimicrob. Chemother. 59:321–322.
19.
BelaaouajA., LapoumeroulieC., CaniçaM.M, VedelG., NévotP., KrishnamoorthyR., and PaulG.1994. Nucleotide sequences of the genes coding for the TEM-like beta-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiol. Lett. 120:75–80.
20.
PitoutJ.D., ThomsonK.S, HansonN.D, EhrhardtA.F, MolandE.S, and SandersC.C.1998. β-lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob. Agents Chemother. 42:1350–1354.
21.
PoirelL., HéritierC., TolünV., and NordmannP.2004. Emergence of oxacillinase mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:15–22.
22.
BatchelorM., HopkinsK., ThrelfallE.J, Clifton-HadleyF.A, StallwoodA.D, DaviesR.H, and LiebanaE.2005. blaCTX-M Genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob. Agents Chemother. 49:1319–1322.
23.
HongS.G., HongS.K, HuhJ.Y, and KangM.S.2012. Multiplex PCR for rapid detection of genes encoding class A carbapenemases. Ann. Lab. Med. 32:359–361.
24.
Van de KlundertJ.A., and VliegenthartJ.S.1993. Nomenclature of aminoglycoside resistance genes: a comment. Antimicrob. Agents Chemother. 37:927–928.
25.
NgL.K., MulveyM.R, MartinI., PetersG.A, and JohnsonW.1999. Genetic characterization of antimicrobial resistance in Canadian isolates of Salmonella serovar Typhimurium DT104. Antimicrob. Agents Chemother. 43:3018–3021.
26.
GuardabassiL., DijkshoornL., CollardJ.M, OlsenJ.E, and DalsgaardA.2000. Distribution and in-vitro transfer of tetracycline resistance determinants in clinical and aquatic Acinetobacter strains. J. Med. Microbiol. 49:929–936.
27.
MadsenL., AarestrupF.M, and OlsenJ.E.2000. Characterization of streptomycin resistance determinants in Danish isolates of Salmonella Typhimurium. Vet. Microbiol. 75:73–82.
28.
MazelD., DychincoB., WebbV.A, and DaviesJ.2000. Antibiotic resistance in the ECOR collection: integrons and identification of a novel aad gene. Antimicrob. Agents Chemother., 44:1568–1574.
29.
MaynardC., FairbrotherJ.M, BekalS., SanschagrinF., LevesqueR.C, BrousseauR., MassonL., LarivièreS., and HarelJ.2003. Antimicrobial resistance genes in enterotoxigenic Escherichia coli O149:K91 isolates obtained over a 23-year period from pigs. Antimicrob. Agents Chemother. 47:3214–3221.
30.
SáenzY., BriñasL., DomínguezE., RuizJ., ZarazagaM., VilaJ., and TorresC.2004. Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins. Antimicrob. Agents Chemother. 48:3996–4001.
31.
KiaeiS., MoradiM., Hosseini-NaveH., ZiasistaniM., and Kalantar-NeyestanakiD.2019. Endemic dissemination of different sequence types of carbapenem-resistant Klebsiella pneumoniae strains harboring blaNDM and 16S rRNA methylase genes in Kerman hospitals, Iran, from 2015 to 2017. Infect. Drug Resist. 12:45–54.
32.
O'ConnorC., CormicanM., BooT.W, McGrathE., SlevinB., O'GormanA., CommaneM., MahonyS., O'DonovanE., PowellJ., MonahanR., FinneganC., KiernanM.G, CoffeyJ.C, PowerL., O'ConnellN.H, and DunneC.P.2016. An Irish outbreak of New Delhi metallo-b-lactamase NDM-1 carbapenemase-producing Enteobacteriaceae: increasing but unrecognized prevalence. J. Hosp. Infect. 94:351–357.
33.
HuX., XuX., WangX., XueW., ZhouH., ZhangL., MaQ., ZhaoR., LiG., LiP., ZhangC., ShiY., WangJ., JiaL., HaoR., WangL., ZouD., LiuX., QiuS., SongH., and SunY.2017. Diversity of New Delhi metallo-beta-lactamase-producing bacteria in China. Int. J. Infect. Dis. 55:92–95.
34.
MarkovskaR., StoevaT., BoyanovaL., StankovaP., SchneiderI., KeuleyanE., MihovaK., MurdjevaM., SredkovaM., LessevaM., NedelchevaG., PetrovaA., IvanovaD., LazarovaG., KanevaR., and MitovI.2019. Multicentre investigation of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Bulgarian hospitals—interregional spread of ST11 NDM-1-producing K. pneumoniae. Infect. Genet. Evol. 69:61–67.
35.
NordmannP., and PoirelL.2014. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin. Microbiol. Infect. 20:821–830.
36.
KazmierczakK., RabineS., HackelM., McLaughlinR., BiedenbachD., BouchillonS., SahmD., and BradfordP.2016. Multiyear, multinational survey of the incidence and global distribution of metallo-β-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 60:1067–1078.
37.
BarguiguaA., El OtmaniF., Lakbakbi El YaagoubiF., TalmiM., ZeroualiK., and TiminouniM.2013. First report of a Klebsiella pneumoniae strain coproducing NDM-1, VIM-1 and OXA-48 carbapenemases isolated in Morocco. APMIS. 121:675–677.
38.
PapagiannitsisC.C., MalliE., FlorouZ., SarrouS., HrabakJ., MantzarlisK., ZakynthinosE., and PetinakiE.2016. Emergence of sequence type 11 Klebsiella pneumoniae coproducing NDM-1 and VIM-1 metallo-β-lactamases in a Greek hospital. Diagn. Microbiol. Infect. Dis. 87:295–297.
39.
BedenicB., SardelicS., LuxnerJ., BosnjakZ., VardaBrkicD., Lukic-GrlicA., MarekovicI., FranculaZaninovicS., KrilanovicM., SijakD., GrisoldA., and ZarfelG.2016. Molecular characterization of class B carbapenemases in advanced stage of dissemination and emergence of class D carbapenemases in Enterobacteriaceae from Croatia. Infect. Genet. Evol. 43:74–82.
40.
KarampatakisT., AntachopoulosC., IosifidisE., TsakrisA., and RoilidesE.2016. Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in Greece. Future Microbiol. 11:809–823.
41.
ProtonotariouF., PoulouA., PolitiL., Sgouro-poulosI., MetallidisS., KachrimanidouM., PournarasS., TsakrisA., and SkouraL.2018. Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in Northern Greece. Int. J. Antimicrob. Agents, 52:331–337.
